Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The peptide downregulates or inhibits key lipogenic enzymes including fatty acid synthase and acetyl-CoA carboxylase, which are responsible for converting excess dietary carbohydrates and other substrates into fatty acids for storage
Its local pharmacological characteristics provide a new idea for the treatment of obesity.AOD 9604, as an anti-obesity polypeptide targeting subcutaneous adipose tissue, achieves the effect of local fat reduction by activating lipolysis and inhibiting fat production
Epitalon is a peptide therapy commonly incorporated into wellness programs designed to support healthy aging, cellular balance, and overall wellness
Mechanism of Action (Research Context) In controlled research environments, retatrutide has been shown to interact with three key metabolic signalling pathways: GLP-1 receptor activity associated with appetite signalling and glucose regulation GIP receptor activity involved in insulin and fat metabolism Glucagon receptor activity linked to energy expenditure and lipid mobilisation This triple-pathway engagement makes retatrutide of particular interest for metabolic and endocrine research models studying obesity, insulin resistance and energy homeostasis
US$ 26.98
US$ 26.64
US$ 22.56
US$ 21.66
